FEN1 Promotes Tumor Progression and Confers Cisplatin Resistance in Non-Small-Cell Lung Cancer

Molecular Oncology - Netherlands
doi 10.1002/1878-0261.12118
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

miRNA‑328 Overexpression Confers Cisplatin Resistance in Non‑small Cell Lung Cancer via Targeting of PTEN

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

High Level of BRD4 Promotes Non-Small Cell Lung Cancer Progression

Oncotarget
Oncology
2016English

Epigenetic Activation of FOXF1 Confers Cancer Stem Cell Properties to Cisplatin‑resistant Non‑small Cell Lung Cancer

International Journal of Oncology
Cancer ResearchOncology
2020English

MicroRNA-661 Promotes Non-Small Cell Lung Cancer Progression by Directly Targeting RUNX3

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2017English

Tumor Evolution in Non-Small-Cell Lung Cancer

ESMO Open
Cancer ResearchOncology
2018English

Cisplatin, Vinblastine, and Bleomycin in Inoperable Non-Small Cell Lung Cancer.

Thorax
PulmonaryRespiratory Medicine
1985English

AFAP1‑AS1 Induces Cisplatin Resistance in Non‑small Cell Lung Cancer Through PI3K/AKT Pathway

Oncology Letters
Cancer ResearchOncology
2019English

MicroRNAs as Regulators of Cisplatin-Resistance in Non-Small Cell Lung Carcinomas

Oncotarget
Oncology
2017English

Elevated RTP801 Promotes Cell Proliferation in Non-Small Cell Lung Cancer

IUBMB Life
BiochemistryGeneticsClinical BiochemistryCell BiologyMolecular Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy